Home/Pipeline/EADO–EUMelaReg ctDNA Project

EADO–EUMelaReg ctDNA Project

Melanoma (Relapse Monitoring)

Clinical Utility StudyActive

Key Facts

Indication
Melanoma (Relapse Monitoring)
Phase
Clinical Utility Study
Status
Active
Company

About Oncobit

Oncobit is a private, commercial-stage diagnostics company based in Lausanne, Switzerland, specializing in liquid biopsy solutions for cancer monitoring. Its core offering is a CE-IVDR-marked digital PCR-based platform and software for detecting and tracking ctDNA, initially focused on melanoma. The company is actively expanding its market presence through strategic partnerships with diagnostic firms like ID Solutions and TrilliumBiO, and is engaged in a major clinical utility study to integrate ctDNA monitoring into routine melanoma follow-up.

View full company profile

Therapeutic Areas